PREVALENCE AND ANTIMICROBIAL SUSCEPTIBILITY PROFILE OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS IN TERTIARY CARE HOSPITAL AT JAIPUR

Dr. Ashina Singla, Dr. Richa Sharma, Dr. Ved Prakash Mamoria

Abstract


Staphylococci are common human commensal and one of the leading cause of infections in human beings. Before the antibiotic era , invasive staphylococcal infections were fatal. Methicillin resistant S. aureus (MRSA) is strain of S. aureus bacterium that is resistant to a large group of antibiotics called the beta-lactams Now a days, MRSA is the main research area in most developed countries due to increased mortality and morbidity. Approximately 20-30% of healthy persons are persistent carriers of S. aureus and 60% are intermittent carriers with high colonization rates among high risk groups including hospital patients and children. In the present study, prevalence and antimicrobial susceptibility pattern of MRSA was reported. A total of 225 samples of Staphylococcus aureus were taken in the present study. Various clinical samples included in the study were pus swab, pus, blood & urine. Out of total 225 Staphylococcus aureus, 88 (39.11%) samples were found to be MRSA. The maximum isolation of MRSA was from pus swabs and pus. So, the present study indicates that there is high incidence of MRSA infections in MGMC&H and also these strains are resistant to most of the antibiotics.


Keywords


MRSA, Pus Swab, Staphylococcus aureus, Resistant.

References


Anupurba, S., Sen, M.R., Nath, G., Sharma, B.M., Gulati, A.K., Mohapatra, T.M. 2003. Prevalence of methicillin resistant Staphylococcus aureus in a tertiary care referral hospital in Eastern UttarPradesh. Indian J. Med. Microbiol., 21: 49–51.

Betty, A.F., Daniel, F.S., Alice, S.W. (Eds), 2002. Staphylococcus, Micrococcus and similar organisms, Chapt. 19. In: Baily and Scott’s diagnostic microbiology, 11 th edn. Mosby Inc: St. Louis. 284 Pp.

Dominique, S., Blanc, et al 2002. Epidemiology of methicillinresistant Staphylococcus aureus: results of a nation- wide survey in Switzerland. Swiss Med. Wkly., 132: 223–9.

Liu, C., Bayer, A., Cosgrove, S..E, Daum, R.S., Fridkin, S.K., Gorwitz, R.J., et al. 2011. Clinical practice guidelines by the infectious disease society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adult and children. Clin Infect. Dis., 52: e18– e55.

Mehta, A.P., Rodrigues, C., Sheth, K., Jani, S., Hakimiyan, A., Fazalbhoy, N. 1998. Control of methicillin resistant Staphylococcus aureus in a tertiary care centre–a five–year study. J. Med. Microbiol., 16: 31–4

Sader, H.S., Farrell, D.J., Jones, R.N. 2010. Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres. Int. J. Antimicrob. Agents, 36: 28–32.

Qureshi, A.H., Rafi, S., Qureshi, S.M., Ali, A.M. 2004. The current susceptibility patterns of methicillin resistant Staphylococcus aureus to conventional anti Staphylococcus antimicrobials at Rawalpindi. Pak. J. Med. Sci., 20: 361–4.


Refbacks

  • There are currently no refbacks.